ArticleClinical rheumatology2020

Propensity score matching/reweighting analysis comparing intravenous golimumab to infliximab for ankylosing spondylitis using data from the GO-ALIVE and ASSERT trials.

L S Gensler et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.